Minimal Residual Disease Market Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2030

Comments · 121 Views

Increasing consumer preferences for tailored therapies is a major factor driving minimal residual disease market revenue growth

Emergen Research has published a research report on global Minimal Residual Disease Market to offer comprehensive analysis of current and emerging market trends along with key developments in the industry. The report offers in-depth information about market share, market size, market revenue growth, drivers, restraints, growth opportunities and challenges. The report also provides insights on different segments such as product types, applications, regional bifurcation along with top companies. The report is curated using primary and secondary research which is thoroughly evaluated by experts in the industry and is well-presented using various pictorial presentations such as tables, diagrams, charts and figures. 

Rising RD activities and increase in research funding from various cancer institutes are major factors projected to support market revenue growth between 2021 and 2030. For instance, Invitae Corporation, based in the U.S., started a research in February 2022 to collect actual data on tailored minimal residual disease diagnostics for distinct tumor types. Inivata also introduced RaDaR assay in April 2020 to identify and track residual disease and relapse in plasma samples of patients with prior cancer diagnoses. In addition, RaDaR assay is based on next-generation sequencing platform InVision liquid biopsy, developed by Inivata, which has built-in control and error checking for highly sensitive and precise variant detection. 

Get Free Brochure of the Report@

The report further explores the key business players along with their in-depth profiling, product catalog, and strategic business decisions. The key players studied in the report are Adaptive Biotechnologies, ARUP Laboratories, Bio-Rad Laboratories, Inc., Cergentis B.V., F. Hoffmann-La Roche Ltd., ICON Plc, Invivoscribe, Inc., Laboratory Corporation of America Holdings, Mission Bio, Natera, Inc., NeoGenomics Laboratories, OPKO Health, Inc., and Sysmex Corporation.

Some Key Highlights From the Report

  • The Polymerase Chain Reaction (PCR) segment accounted for a significant revenue share in 2021. PCR examines specific DNA segments for unusual genetic traits. The test increases DNA to make it simpler to identify and count unusual characteristics and blood cells or bone marrow can be used. PCR tests can still detect it, if there is only one cancer cell in a group of 100,000 to 1 million healthy cells.
  • The hospitals segment accounted for largest revenue share in 2021 owing to availability of various treatment options and frequent patient visits. Hospitals consistently offer services for both acute and complicated diseases, which improves and complements performance of many other parts of the healthcare system.
  • The North America market accounted for largest revenue share in 2021 owing to increasing prevalence of blood cancer and rising investments from cancer institutions. In addition, rising incidence of hematological cancers in the U.S. is increasing risk of MRD and is expected to drive revenue growth of the market in this region.

Browse the complete Global Minimal Residual Disease Market Research Report@

Emergen Research has segmented the global minimal residual disease market based on indication, detection, treatment methods, treatment centers, and region:

  • Indication Outlook (Revenue, USD Million; 2019–2030)

    • Leukemia
      1. Acute Lymphoblastic Leukemia (ALL)
      2. Chronic Lymphoblastic Leukemia (CLL)
      3. Acute Myeloid Leukemia (AML)
      4. Chronic Myeloid Leukemia (CML)
      5. Others
    • Lymphoma
      1. Non-Hodgkin’s Lymphoma (NHL)
      2. Marginal Zone Lymphoma
      3. Follicular Lymphoma
      4. Peripheral T-cell Lymphoma
      5. Mantle Cell Lymphoma
      6. Others
    • Multiple Myeloma (MM)
    • Solid Tumor
    • Others
  • Detection Outlook (Revenue, USD Million; 2019–2030)

    • Next-Generation Sequencing (NGS)
    • Flow Cytometry
    • Polymerase Chain Reaction (PCR)
    • Fluorescence In-Situ Hybridization (FISH)
    • Others
  • Treatment Methods Outlook (Revenue, USD Million; 2019–2030)

    • Chemotherapy
    • Stem Cell Transplant
    • CAR-T Cell Therapy
    • Others
  • Treatment Centers Outlook (Revenue, USD Million; 2019–2030)

    • Hospitals
    • Oncology Treatment Centers
    • Diagnostic Centers Research Institutions
    • Specialty Clinics
    • Others

Regional Bifurcation of the Minimal Residual Disease Market Includes:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The report aims to provide a complete analysis of the global Minimal Residual Disease market with important details about the key market players from insightful primary and secondary research data. The report also aims to benefit the user by providing constructive data to gain insight into market growth, size, and investment approaches. Additionally, the report provides an extensive analysis of the Minimal Residual Disease market, including key data, such as factors influencing the growth of the market, buyers and vendors, production and consumption, and revenue.

Request a discount on the report @

Highlights of Table of Contents (TOC):

  • Overview of Global Minimal Residual Disease Market
  • Competitive analysis of the Minimal Residual Disease market
  • Regional analysis of Global Minimal Residual Disease market production and revenue
  • Regional analysis of Global Minimal Residual Disease market supply, consumption, and export import
  • Type-based market analysis of global Minimal Residual Disease production, revenue, and price trends
  • Application-based analysis of the global Minimal Residual Disease market
  • Manufacturer profiles, manufacturing cost, and upstream and downstream analysis of global Minimal Residual Disease market
  • Global Minimal Residual Disease market forecast (2020-2027)
  • Conclusion of the research report

Request customization of the report @

Take a Look at our Related Reports:

Sports Medicine Market

Wireless Earbuds Market

Thermal Interface Materials Market

Insulation Materials Market

Cancer Tumor Profiling Market

Thank you for reading the research report. We also offer report customization as per client requirement. Kindly connect with us to know more about the customization feature and our team will offer you the best suited report. 

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Smart Learning Market | IoT Sensors Market

Latest Report: Smart Home Devices Market | Variable Rate Technology Market